Silence Therapeutics (SLN)
NASDAQ: SLN
· Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Aug 15, 2025, 3:59 PM
5.49
0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT
Silence Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 142K | 24.33M | 1.14M | 598K | 12.41M | 2.1M | 2.8M | 9.1M | 11.37M | 4.76M | 3.37M | 3.64M | 5.72M | 3.41M | 3.16M | 2.7M | 3.14M |
Cost of Revenue | 54K | 1.61M | 2.77M | 2.64M | 2.21M | 1.35M | 1.61M | 2.83M | 4.53M | 3.86M | 2.39M | 2.35M | 2.27M | 2.04M | 2.05M | 1.82M | 1.54M |
Gross Profit | 88K | 22.72M | -1.63M | -2.04M | 10.19M | 753K | 1.19M | 6.27M | 6.84M | 906K | 977K | 1.29M | 3.45M | 1.37M | 1.1M | 876K | 1.61M |
Operating Income | -28.41M | -3.08M | -22.54M | -18.32M | -4.16M | -13.3M | -12.7M | -11.46M | -12.15M | -10.96M | -13.62M | -14.09M | -9.92M | -11.26M | -12.28M | -12.93M | -9.34M |
Interest Income | n/a | 886.95K | 981K | 1.06M | 804K | n/a | 2.05M | 340K | 336K | 10K | 4.33M | 669K | 350K | 2K | 296K | 219K | 2K |
Pretax Income | -28.53M | 23.74M | -30.16M | -17.44M | -3.37M | -14.97M | -10.66M | -12.01M | -12.67M | -15.05M | -9.33M | -13.42M | -9.57M | -11.23M | -12.05M | -12.71M | -9.87M |
Net Income | -28.53M | 14.17M | -27.01M | -15.56M | -1.88M | -14.41M | -8.25M | -10.4M | -10.2M | -13.76M | -7.1M | -11.94M | -7.68M | -9.43M | -9.93M | -11.63M | -8.42M |
Selling & General & Admin | 7.68M | 5.4M | 5.6M | 5.29M | 5.17M | 4.12M | 4.96M | 5.12M | 6.45M | 3.47M | 5.83M | 4.55M | 5.77M | 5.41M | 5.47M | 5.38M | 3.75M |
Research & Development | 20.81M | 20.4M | 15.3M | 10.99M | 9.18M | 9.94M | 8.93M | 12.62M | 12.54M | 8.4M | 8.77M | 10.83M | 7.6M | 7.22M | 7.92M | 8.17M | 7.46M |
Other Expenses | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 259K | -259K |
Operating Expenses | 28.5M | 25.8M | 20.91M | 16.28M | 14.35M | 14.05M | 13.89M | 17.73M | 18.99M | 11.87M | 14.6M | 15.38M | 13.37M | 12.63M | 13.39M | 13.8M | 10.95M |
Interest Expense | n/a | -11.54M | 8.6M | 183K | 13K | 928K | 8K | 893K | 860K | n/a | 34K | n/a | n/a | n/a | 64K | n/a | 531K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.55M | 27.41M | 23.68M | 18.92M | 16.56M | 15.4M | 15.5M | 20.56M | 23.52M | 15.73M | 16.99M | 17.73M | 15.64M | 14.68M | 15.44M | 15.63M | 12.48M |
Income Tax Expense | n/a | 9.56M | -3.15M | -1.88M | -1.49M | -554K | -2.41M | -1.61M | -2.47M | -1.29M | -2.22M | -1.48M | -1.89M | -1.79M | -2.12M | -1.08M | -1.45M |
Shares Outstanding (Basic) | 47.23M | 47.22M | 46.74M | 46.74M | 43.96M | 38.92M | 37.31M | 36.16M | 35.98M | 32.19M | 32.91M | 29.93M | 29.93M | 29.65M | 29.91M | 29.89M | 28.85M |
Shares Outstanding (Diluted) | 47.23M | 47.22M | 46.74M | 46.74M | 43.96M | 38.92M | 37.31M | 36.16M | 35.98M | 32.19M | 32.91M | 29.93M | 29.93M | 29.65M | 29.91M | 29.89M | 28.85M |
EPS (Basic) | -0.6 | 0.31 | -0.57 | -0.33 | -0.04 | -0.36 | -0.22 | -0.29 | -0.28 | -0.42 | -0.22 | -0.39 | -0.26 | -0.33 | -0.33 | -0.39 | -0.29 |
EPS (Diluted) | -0.6 | 0.31 | -0.57 | -0.33 | -0.04 | -0.36 | -0.22 | -0.29 | -0.28 | -0.42 | -0.22 | -0.39 | -0.26 | -0.33 | -0.33 | -0.39 | -0.29 |
EBITDA | -28.41M | 7.19M | -21.44M | -17.14M | -4.04M | -14.91M | -10.53M | -11M | -11.68M | -10.88M | -9.18M | -13.31M | -9.46M | -11.2M | -11.88M | -12.59M | -9.21M |
EBIT | -25.73M | 7.07M | -21.56M | -17.26M | -3.35M | -15.03M | -10.65M | -11.12M | -11.81M | -15.04M | -9.29M | -13.42M | -9.57M | -11.3M | -11.99M | -12.71M | -9.34M |
Depreciation & Amortization | 138K | 119.28K | 115K | 119K | 120K | 121K | 125K | 118K | 134K | 141K | 114K | 114K | 113K | 66K | 110K | 123K | 128K |